Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Pfizer Stock a Buy?


's (NYSE: PFE) share price has fallen more than the S 500 so far this year. The big pharma stock is nearly 60% below its high set in late 2022. By most standards, Pfizer looks like the proverbial knife in the investing adage, "Don't try to catch a falling knife."

But could Pfizer stock be a smart pick to buy right now? I think there's more than one answer.

If you're a growth investor, you probably won't be interested in buying Pfizer stock. And I don't make that assumption based on Pfizer's abysmal performance in recent years. The reality is that the drugmaker faces serious headwinds in the near future, too.

Continue reading


Source Fool.com

Pfizer Inc. Stock

€23.28
-1.620%
A loss of -1.620% shows a downward development for Pfizer Inc..
We see a rather positive sentiment for Pfizer Inc. with 14 Buy predictions and 2 Sell predictions.
As a result the target price of 27 € shows a slightly positive potential of 15.98% compared to the current price of 23.28 € for Pfizer Inc..
Like: 0
PFE
Share

Comments